Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas

• Κύριοι συγγραφείς: Opal L. Reddy (Συγγραφέας), Peter I. Shintaku (Συγγραφέας), Neda A. Moatamed (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: BMC, 2017-06-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Abstract Background The programmed death-1/programmed death-ligand-1 (PD-1/PD-L1) immune regulatory axis has emerged as a promising new target for cancer therapeutics, with lasting responses seen in the treatment of metastatic renal and lung carcinomas, as well as melanomas. As tumor surface express...